This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4i11
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.== | ==Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.== | ||
| - | <StructureSection load='4i11' size='340' side='right' caption='[[4i11]], [[Resolution|resolution]] 1.89Å' scene=''> | + | <StructureSection load='4i11' size='340' side='right'caption='[[4i11]], [[Resolution|resolution]] 1.89Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4i11]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4i11]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4I11 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4I11 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1CH:N-(3,3-DIMETHYL-3,4-DIHYDROISOQUINOLIN-1-YL)-L-PHENYLALANINE'>1CH</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1CH:N-(3,3-DIMETHYL-3,4-DIHYDROISOQUINOLIN-1-YL)-L-PHENYLALANINE'>1CH</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4i11 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4i11 OCA], [https://pdbe.org/4i11 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4i11 RCSB], [https://www.ebi.ac.uk/pdbsum/4i11 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4i11 ProSAT]</span></td></tr> | |
| - | + | ||
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/BACE1_HUMAN BACE1_HUMAN] Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase.<ref>PMID:10677483</ref> <ref>PMID:20354142</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 20: | ||
==See Also== | ==See Also== | ||
| - | *[[Beta secretase|Beta secretase]] | + | *[[Beta secretase 3D structures|Beta secretase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Artis | + | [[Category: Artis DR]] |
| - | [[Category: Beroza | + | [[Category: Beroza P]] |
| - | [[Category: Bova | + | [[Category: Bova M]] |
| - | [[Category: Bowers | + | [[Category: Bowers B]] |
| - | [[Category: Brecht | + | [[Category: Brecht E]] |
| - | [[Category: Chan | + | [[Category: Chan W]] |
| - | [[Category: Hom | + | [[Category: Hom RK]] |
| - | [[Category: Konradi | + | [[Category: Konradi AW]] |
| - | [[Category: Lougheed | + | [[Category: Lougheed J]] |
| - | [[Category: Pan | + | [[Category: Pan H]] |
| - | [[Category: Probst | + | [[Category: Probst GD]] |
| - | [[Category: Sham | + | [[Category: Sham HL]] |
| - | [[Category: Tam | + | [[Category: Tam D]] |
| - | [[Category: Xu | + | [[Category: Xu Y]] |
| - | [[Category: Yao | + | [[Category: Yao N]] |
| - | [[Category: Yuan | + | [[Category: Yuan S]] |
| - | [[Category: Zhu | + | [[Category: Zhu YL]] |
| - | + | ||
| - | + | ||
Current revision
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
| |||||||||||
Categories: Homo sapiens | Large Structures | Artis DR | Beroza P | Bova M | Bowers B | Brecht E | Chan W | Hom RK | Konradi AW | Lougheed J | Pan H | Probst GD | Sham HL | Tam D | Xu Y | Yao N | Yuan S | Zhu YL
